Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 2,821–2,880 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

Affymetrix Research Services Laboratory1 Africa1 Africa Centre for Disease Control1 Africa Centres for Disease Control and Prevention1 Africa Health Research Institute1 Africa Journals Online1 African Journals1 African higher education institutions1 African-Wide EBSCO1 Agaba J1 Age 40 Program1 Agence Nationale de Sécurité du Médicament1 Agence Nationale de Sécurité du Médicament et des Produits de Santé1 Agence Nationale de la Recherche1 Agencia Española del Medicamento y Productos Sanitarios1 Agency for Health Quality and Assessment of Catalonia1 Agency for Science, Technology and Research1 Agenzia Nazionale per i Servizi Sanitari Regionali1 Agilent1 Agilent BioTek1 Agilent Technologies1 Agricultural Health Study cohort1 Ahmadu Bello University Teaching Hospital1 Ahn et al1 Airwave Health Monitoring Study1 Ajanta Pharma1 Akershus Cardiac Examination 1950 Study1 Akhgar et al.1 Akkari et al1 Al Ain hospital1 Al Bashir et al191 Al-Aqsa Martyrs Hospital1 Al-Basheer Hospital1 Al-Hada Armed Forces Hospital1 Al-Hada Armed Forces tertiary hospital1 Al-Kadhimiya Teaching Hospital1 Al-Mousa et al211 Al-Moussally et al1 Al-Nahrain University1 Al-Shifa Hospital1 Alamut1 Alawieh et al.1 Albany Medical Center1 Albert Einstein Cancer Center1 Alberta Stroke Program1 Alborz University of Medical Sciences1 Albright et al1 Alder Hey1 Alexandria Main University Hospital1 Alfred Health1 Alfred Hospital Ethics Committee1 Aligarh Muslim University1 Alkholy et al.1 All India Institute for Medical Sciences1 All India Institute of Medical Sciences Bhubaneswar Extended Health Clinic1 Allegheny Health Network1 Allegheny Health Network (AHN) Cancer Institute1 Allegheny Health Network Institutional Review Board1 Allen Human Brain Atlas1 Allergy UK1

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 314 of 946

655 Theranostic PET defines a ‘goldilocks zone’ for focused ultrasound ablation: balancing tumor disruption and immunotherapeutic antibody delivery

jitc · abstract · 2025-11-04 · 2 matching annotations

96.5%

University of Virginia [89Zr]-αCD47 [89Zr]-aCD47 breast cancer solid tumors NIH DP5OD031846 breast tumors [18F]-Fludeoxyglucose T-FUS

…d regulations of the University of Virginia and approved by the University of Virginia Animal Care and Use Committee.References Demir ZEF, Sheybani ND…

656 Focused ultrasound thermal ablation and CD40 agonist drive tumor regression and immunologic memory via innate and adaptive reprogramming in breast cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

94.1%

University of Virginia cancer breast cancer BC NIH DP5OD031846 αCD40 T-FUS

…d regulations of the University of Virginia and approved by the University of Virginia Animal Care and Use Committee.Abstract 656 Figure 1Subtotal T-F…

658 KAN-001, a defined live biotherapeutic product (LBP) for NSCLC, enhances ICI response in preclinical models and demonstrates manufacturing consistency and strain-resolved viability

jitc · abstract · 2025-11-04 · 2 matching annotations

96.5%

MD Anderson Cancer Center CRCHUM KAN-001 non-small cell lung cancer NSCLC anti-PD-1 therapy Canadian Council PD-1 therapy

…Acknowledgements We thank Nadim Ajami and Jennifer Wargo of the MD Anderson Cancer Center for their continued support of the KAN-001 program.Ethics Appro…

665 TROP2 remodeling of the immune microenvironment in triple negative breast cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

92.9%

Massachusetts General Hospital MGH Histopathology Research Core TNBC Immunomedics/Gilead Sacituzumab govitecan triple-negative breast cancer human breast cancer immunotherapy chemotherapy

… approved by the Institutional Animal Care and Use Committee at Massachusetts General Hospital (Protocol #:2004N000228).…

668 Fatty acid metabolism promotes innate immune evasion and resistance to immunotherapy in irradiated glioblastoma

jitc · abstract · 2025-11-04 · 2 matching annotations

82.9%

TCGA glioblastoma FASNi anti-PD-1 IACUC #2019-0042

…ere abrogated by deletion of cGAS, RIG-I, or MDA5. Importantly, TCGA pan-cancer analysis revealed that FASN expression inversely cor…

670 Proton radiotherapy alone versus combined with immunotherapies or tyrosine kinase inhibitors for barcelona clinic liver cancer stage B or C hepatocellular carcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

93.9%

Linkou Chang Gung Memorial Hospital Chang Gung Medical Foundation lenvatinib sorafenib atezolizumab-bevacizumab pembrolizumab Proton radiotherapy hepatocellular carcinoma HCC Proton-TKI

…cer (BCLC) stage B or C HCC treated with proton radiotherapy at Linkou Chang Gung Memorial Hospital between 2020 and 2023. Patients were stratified into three grou…

679 Combined radiation and adoptive CTL therapy in advanced extramammary paget disease with pulmonary and nodal metastases: a case report and rationale for case series expansion

jitc · abstract · 2025-11-04 · 2 matching annotations

87.0%

Radiother Oncol Proc Natl Acad Sci USA melanoma-specific Extramammary Paget’s disease (EMPD)IL-2 EMPD melanoma solid tumors Adoptive CTL therapy EBV-related cancers+1 more

…fter progression on immunotherapy: Results of a phase II trial. Radiother Oncol. 2021 Sep;162:60-67. doi: 10.1016/j.radonc.2021.06.037. Epub 20…

680 Assessing outcomes in melanoma patients with brain metastases: a retrospective study of immunotherapy, radiation, and surgical treatment sequencing

jitc · abstract · 2025-11-04 · 2 matching annotations

94.8%

Brown University Health Lifespan- Rhode Island Hospital Institutional Review Board melanoma ipilimumab nivolumab Brain metastases advanced melanoma surgery ICI

…ort study of melanoma patients with brain metastases treated at Brown University Health between 2005 to 2024. Patients were categorized based on the se…

690 Boosting treatment outcomes for high-grade serous ovarian cancer via the integration of antibody-drug conjugates and immune system stimulants

jitc · abstract · 2025-11-04 · 2 matching annotations

95.6%

Imperial College London University of Alabama at Birmingham Trastuzumab emtansine trastuzumab High-grade serous ovarian carcinoma (HGSOC)CBD-IL-7 epithelial ovarian cancer T-DM1PMPC CBD-IL-12 T-DM1

…edgements CBD-IL-7 and CBD-IL-12 generated by Dr. Jun Ishihara, Imperial College London.Ethics Approval This study was approved by the Institutional An…

692 Targeting ICOS receptor to improve breast cancer immunotherapy

jitc · abstract · 2025-11-04 · 2 matching annotations

80.4%

Austin Health Animal Ethics Committee Victorian Cancer Agency breast cancer lung cancer melanoma NBCF

…al Animal Studies - Animal-related studies were approved by the Austin Health Animal Ethics Committee - Application number A2021_05727. Human Sample Collection - Hum…

702 Pulsed electrical field ablation plus intratumoral immunotherapy for head and neck squamous cell carcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

78.7%

Int J Mol Sci squamous cell carcinoma HNSCC intra-tumoral immunotherapy injection pulsed electrical field ablation hepatocellular carcinoma

…ting prognosis and therapy outcome of hepatocellular carcinoma. Int J Mol Sci. Feb 08 2023;24(4).Jardim DL, Goodman A, de Melo Gagliato D, Ku…

734 Tertiary lymphoid structures as hallmarks of response to neoadjuvant chemoimmunotherapy in locally advanced non-small cell lung cancer NADIM trial

jitc · abstract · 2025-11-04 · 2 matching annotations

95.2%

Hospital Puerta de Hierro nivolumab NSCLC Resectable Lung Cancer

…tocol was approved by the clinical research ethics committee of Hospital Puerta de Hierro (ref. 20.16) and the Spanish Lung Cancer Group (SLCG) Board (re…